Schedule 13G ownership disclosure
Sucampo Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 864909106
Event date: 2017-12-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-364606
- Form type
- SC 13G
- Filer
- Linden Capital L.P.
- CIK
- CIK 1349339
- Filed
- Dec 08, 2017
- Reporting period
- Dec 06, 2017
- Description
- Schedule 13G beneficial ownership